Patents – can you continue to ignore them?


Chris MasonSenior Associate Patent Attorney - Appleyard Lees

Time & Location

Thursday: 10.00 to 10.20, Stage 2

About this presentation

What are the risks associated with ignoring patents and not setting out a practical patent strategy for your business?  This session will share the benefit of decades of accumulated knowledge and experience working with chemical companies in the UK.  We will discuss how patents can help to drive your business forward and consider whether any chemical business can afford to take a head-in-the-sand approach.  Whether it is a competitor showing up out of the blue with a patent for seemingly old rope, or failing to fully capture the value that your business is adding, we will talk through the pitfalls and share some top tips toward an effective strategy, which starts with making decisions from an informed position.

Panellist bio:

As a Chartered UK and European Patent Attorney, Chris works with his clients to develop and deliver pragmatic patent strategies that capture innovation, generate valuable assets and protect freedom to operate.

Chris represents a wide range of chemical clients, from start-ups and SMEs to multinational corporations. Chris has particular experience of working directly with R&D departments that extend across different territories, for example across the UK, continental Europe and the US, and advising in relation to process innovations.

Day-to-day Chris handles cases in fields that include the commodity and speciality chemicals sectors; pharmaceuticals; and healthcare, involving technologies such as new synthetic polymers, catalysts, ceramics, additives, APIs, formulations and medical devices.

Chris also likes to maintain an involvement with the wider chemical community through activities with the Royal Society of Chemistry (RSC).  Chris currently serves as treasurer of the RSC Central Yorkshire Section and sits on the committee of the RSC’s Law Group.  Chris also regularly gives talks aimed at sharing insights into patent strategy best practice.